InvestorsHub Logo
Followers 0
Posts 2393
Boards Moderated 0
Alias Born 09/22/2012

Re: mkaiz post# 15730

Saturday, 08/02/2014 11:33:35 AM

Saturday, August 02, 2014 11:33:35 AM

Post# of 20775
They had to get the house in order first no one was willing to finance this with the same majority holder in control sorry to say it.Past does have a way to bite one in the butt.Its really sad but its called life/wallstreet.

Said last summer alot more cuts/pain had to occur.Said Oind would denie the motion to dismiss the complaint and dismiss the second claim if Sharipo did not have more evidence.What happened?Read what Oing decided and the wording of that decision.

When I said pain I'm talking about the near 20 million in insider losses that occured after the breach of contract by Pfizer.

I own what I own and want sell down here I rather eat my hat.At some point I've no choice but to buy more.Thats just me.I've been called a follower which to me makes no sense.

I'm still playing this for a major events before I trade.One being the settlement or judgement against Pfizer or it could be a partnership with big pharma or one of the ongoing trials is positive.

One thing for sure I done alot of DD.Some ended up worthless some ended up factual some pending.

I started my first trade when we got the patent news regarding Ponezumab.No one knew or expected Pfizer to renege.

Now that being said on thing I know for sure is I'm not a idiot when it comes to law.I've read every court filing on both sides many many many times.

Without any doubt not as a follower but in my past experience its clear to me Intellect has a valid claim against Pfizer and its clear based on the court record Oing knows what occured.

I base my decision on the wording judge Oing used on the record.Not what he thinks the plantiff or defense is stating nor what he understands them to be saying but what judge Oing is saying.

IMO a settlement of 2 million makes ILNS .025 to .05 if its anything in there for the breach it may trade between .05 to .10.Not a bad trade if either target meets expections.


THE COURT: Not according to the way this contract, at least the arguments I heard. Maybe I misunderstood the contract

You really think Oing misunderstood the contract he read.He's only been doing this forever.The wording maybe (I)

THE COURT: You know, its interesting when you say that the drug itself or the compound itself doesn't and you stop using it. That's so much -- that's still--

It just doesn't matter --the way I read this argument or read the complaint or the contract here is that once you get an issued patent that's enough at this point to get the milestone triggered

Look real close at the wording.The way(I)read this

Enough said the defese is toast regarding the breach.What they really need to be concerned with is additional claims being filed when Shapiro gets that evidence I already talked about last summer or the ammo Oing refers to on the decision to denie the motion to dismiss.




Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.